SOLID ADVANCED TUMOR
Clinical trials for SOLID ADVANCED TUMOR explained in plain language.
Never miss a new study
Get alerted when new SOLID ADVANCED TUMOR trials appear
Sign up with your email to follow new studies for SOLID ADVANCED TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New PD-1 blocker aims to shrink advanced tumors
Disease control Recruiting nowThis study tests a new drug called OSE-279 that blocks PD-1, a protein that can stop the immune system from attacking cancer. It is for people with advanced solid tumors or lymphomas that have not responded to other treatments. The study has three parts: first finding a safe dose…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a combination of two drugs, MCLA-129 and ensartinib hydrochloride, in people with advanced solid tumors that cannot be removed by surgery or cured. The goal is to see if the combination is safe and can shrink or control the tumors. About 164 adults aged 18-75 wit…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:33 UTC